S&P 500
2078.61
+7.96 +0.38%
Dow Indu
17960.21
+155.41 +0.87%
Nasdaq
4781.42
+16.04 +0.34%
Crude Oil
55.32
-1.81 -3.13%
Gold
1174.510
-23.500 -1.96%
Euro
1.224135
-0.000330 -0.03%
US Dollar
89.751
+0.235 +0.30%
Weak

COTTON #2 Mar 2015 (E) Future

IntercontinentalExchange/NY BoardCOTTON #2 Mar 2015 (E) (NYBOT:CT.H15.E)

62.12 +1.23 (+2.02%)

2014-12-22 14:19:16, 30 min delay

COTTON #2 Mar 2015 (E) (NYBOT:CT.H15.E) Future Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price62.12
Settle Time14:19
Previous Close60.93
Low60.46
Open Int.122312
Contract High83.77
Contract Low58.53
Estimated Volume3125
Expiration2015-03-09
Close Time14:20
Net Change1.23
Open60.51
High62.17
Volume16,906
Time2014-12-22 14:19:16
Contract High Date2014-05-08
Contract Low Date2014-11-24
First Delivery2015-03-23
Open Time21:00

Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for COTTON #2 Mar 2015 (E) (CT.H15.E) now.

Symbol
First Name
Last Name
Email
 

By filling out the form, you'll receive access to trend analysis, educational videos, and other trading resources from INO.com. Trend Analysis will be sent directly to your inbox.


Trader's Blog

The 5 Keys To Trading And The 1 Key To Your Success
   3 hours ago
10 Days Left - MarketClub Holiday Membership Rate
   1 day ago
Sterling Back in the Game?
   1 day ago

Today's Financial News

Oil patch officials say drilling downturn won't slow housing, infrastructure demands

4 hours ago

BISMARCK, N.D. (AP) — City officials in the North Dakota oil patch say they are forging ahead with housing and infrastructure projects, despite an expected downturn in drilling in the next year. "Basically, based on projections for a need of 7,000 permanent housing units, we're only at about 2,000," Sanford said. "We're so far away. We can't let our foot off the pedal here."

Achillion rises as company says combo of hepatitis C drugs cured all patients in small study

4 hours ago

NEW YORK (AP) — Shares of Achillion Pharmaceuticals advanced Monday after the company said a combination of two experimental hepatitis C drugs cured all patients in a small clinical trial. Shares of Achillion Pharmaceuticals Inc. climbed $1.56, or 11 percent, to $15.77 in morning trading. Earlier the stock rose to $16.74, its highest price in almost eight years.

Express Scripts to shift coverage away from pricey hepatitis C drugs like Sovaldi

4 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a new drug from AbbVie while pulling back on more expensive options from rival drugmakers. Express Scripts will still cover the other drugs if patients have already started treatment or if the patient has a clinical exception and needs those particular drugs.

Correction: Marijuana Research story

4 hours ago

DENVER (AP) — In a story Dec. 17 about marijuana research, The Associated Press reported erroneously reported Marcel Bonn-Miller's profession. He is a psychologist, not a psychiatrist. Also, while he works with the Veterans Administration, his lab is not part of the VA. Colorado funds medical marijuana research, a first

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.